Quidel

News Release

Printer Friendly Version View printer-friendly version
<< Back
Quidel Fourth Quarter and 2004 Financial Results Conference Call Alert

SAN DIEGO--(BUSINESS WIRE)--Feb. 2, 2005--Quidel Corporation (Nasdaq:QDEL), a leading provider of rapid point-of-care diagnostic tests, will release fourth quarter and full year 2004 financial results after market close on Wednesday, February 16, 2005.

Following the release of the results, Caren L. Mason, president and chief executive officer, and Paul E. Landers, senior vice president and chief financial officer, will host an investment community conference call beginning at 5:00 p.m. ET (2:00 p.m. PT) to discuss those results and to answer questions.

To participate in the live call by telephone, from the U.S., dial (888) 803-7396, or from outside the U.S. dial (706) 634-1052. A live web cast of the call can be accessed at www.quidel.com. The web site replay will be available for 14 days and the telephone replay will be available for 48 hours by dialing (800) 642-1687 from the U.S., or (706) 645-9291 for international callers, and entering reservation number 3723074.

About Quidel

Quidel Corporation helps women and their families live healthy lives, through the discovery, development and manufacture and marketing of point of care (POC) rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions associated with women's and family health in areas including reproduction, upper respiratory infections and other clinical conditions. Its broad line of POC diagnostics includes influenza A and B, Strep throat, pregnancy, H. pylori infection, chlamydia, infectious mononucleosis and infectious vaginitis. Quidel's products are sold to healthcare professionals for use in physician offices and clinical laboratories, and to consumers through several distribution partners. For more information, please visit www.quidel.com

CONTACT: Quidel Corporation
Paul E. Landers, 858-552-7962
or
Lippert/Heilshorn & Associates
Ina McGuinness or Bruce Voss, 310-691-7100
imcguinness@lhai.com
bvoss@lhai.com

SOURCE: Quidel Corporation